Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis Patients

2021 ◽  
Vol 47 ◽  
pp. 102635
Author(s):  
Devon S Conway ◽  
Sarah M Planchon ◽  
Se Hong Oh ◽  
Kunio Nakamura ◽  
Nicolas R Thompson ◽  
...  
2018 ◽  
Vol 31 (3) ◽  
pp. 346-363 ◽  
Author(s):  
Hanni Kiiski ◽  
Lee Jollans ◽  
Seán Ó. Donnchadha ◽  
Hugh Nolan ◽  
Róisín Lonergan ◽  
...  

2004 ◽  
Vol 10 (6) ◽  
pp. 626-629 ◽  
Author(s):  
Darcy Cox ◽  
Daniel Pelletier ◽  
Claude Genain ◽  
Sharmila Majumdar ◽  
Ying Lu ◽  
...  

Objective: The purpose of this study was to examine the relationships between cognitive functioning, whole brain magnetic transfer ratio (MTR) imaging, supratentorial 1H-magnetic resonance spectroscopy imaging (1HMRSI), and conventional T1 and T2 imaging in a homogenous sample of SPMS patients. Methods: Nineteen patients underwent a single 90-min imaging session that obtained T1-and T2-weighted images and MTR. 1HMRSI was obtained on 14 of these patients. Patients underwent a neuropsychological battery, which was used to create an integrated measure of cognitive impairment. Cognitive impairment was the dependent variable in two hierarchical multiple regression analyses in which T2 lesion load, T1 lesion load, and MTR or NAA/Cr were entered sequentially. Results: MTR was significantly related to cognitive functioning (ΔR2= 0.22, P= 0.02) after accounting for T2 lesion load (ΔR2=0.33, P= 0.01) and T1 lesion load (ΔR2= 0.00, P=0.98). NAA/Cr was not significantly related to cognitive functioning. Conclusions: Cognitive dysfunction may act as a clinical marker of normal appearing brain tissue pathology in multiple sclerosis.


2021 ◽  
Vol 19 (01) ◽  
pp. 21-29
Author(s):  
JIA WEARN CHONG ◽  
NORMAH CHE DIN ◽  
PAULINE JOSEPH JOYCE

Cognitive impairment is the most disabling symptoms of Multiple Sclerosis (MS). Researchers have been studying factors that could predict cognitive impairment among MS patients hoping to alleviate its consequences and gather indicators of the disease progression. However, there were limited up-to-date articles that review the predictors of cognitive impairment among MS patients. In Malaysia, the topic about cognitive functioning in MS was absent. This review aims to identify and synthesize the research evidence concerning biopsychosocial variables on cognitive impairment among this population for future directions in Malaysia researches. A narrative review was performed by identifying research articles from year 2004 to 2019 through PubMed, EBSCOhost, Scopus and Google Scholar. Full-text articles meeting the selection criteria were included for qualitative synthesis. A total of 12 studies were included. Studies included in this paper found that age, course of disease and anxiety predicts cognitive functioning. Mixed results were found among variables such as gender, disability, fatigue, burden of lesion, depression and educational level. Stress was correlated with cognitive functioning but it was not a significant predictor. Although many factors were found to affect cognitive functioning among MS patients, evidence provided from this review indicates that their relationships might not be linear and direct.


Sign in / Sign up

Export Citation Format

Share Document